Prosecution Insights
Last updated: August 06, 2026

Wolter Van Dyke Davis, Pllc

45 pending office actions • 27 clients • 41 examiners • 31 art units • 0 of 45 (0%) have an AI response strategy ready

Quality Metrics (n=3390 apps, methodology: how we score firms)

85.2%
Allowance Rate
n=3390
+0.65σ
Allowance Rate (norm)
n=3390
3.3
OAs to Allowance
n=1979
-0.20σ
OAs to Allow (norm)
n=1979
1077 days
Time to Allowance
n=1979
+12.7pp
Interview Lift
n=3390
22.6%
RCE Rate
n=3390
1.8%
Appeal Rate
n=3390

Rejection Performance (% of received rejections ultimately overcome)

77.7%
§101 Overcome
n=256
80.5%
§102 Overcome
n=942
81.8%
§103 Overcome
n=1514
82.8%
§112 Overcome
n=1367

Specialization & Scale

F01D, F05D, A61K
Top CPC Subclasses
17%
Top-3 CPC Share
n=3390
3
Practitioners
n=3390
1130.0
Apps / Practitioner
n=3390

Portfolio Summary

45
Total Pending OAs
32
Non-Final OAs
9
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
0
Due this week
4
Due this month
3
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 30 days (4)Due ≤ 60 days (3)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

25
Hard (56%)
16
Medium (36%)
4
Easy (9%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other8 (18%)
§103 only11 (24%)
§102 only3 (7%)
§112 only4 (9%)
Double-patenting + other2 (4%)
Multi-statute (no §101)16 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

35
Life Sciences
78% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
2% of docket
4
Mechanical / Eng
9% of docket
5
Business / Other
11% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

450 h
Manual time on pending OAs
90 h
Time saved (low, 20%)
158 h
Time saved (mid, 35%)
3.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GEISBERT, WILLIAM ADDISON 4 34.8% +36.7%
CHATTERJEE, JAYANTA 2 47.4% +76.9%
KENNEDY, TIMOTHY J 1 71.2% +17.4%
AURORA, REENA 1 87.1% -13.4%
NIGAM, NATASHA 1 61.5% +38.3%
MELLOTT, JAMES M 1 50.8% +45.3%
LI, CHANGQING 1 29.6% +33.1%
DEMEREE, CHRISTOPHER R 1 69.0% +13.9%
DESAI, ANISH P 1 44.8% +7.5%
AHVAZI, BIJAN 1 63.4% +47.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18998662 SINGLE CRYSTAL SAPPHIRE COMPONENT FOR ANGULAR CONTROL DURING SOLID STATE NUCLEAR MAGNETIC RESONANCE MEASUREMENTS AURORA, REENA

Hard Cases (25)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18627775 METHODS FOR PASSIVATING PEROVSKITE SOLAR CELLS AND RELATED DEVICES PILLAY, DEVINA 80d overdue
18021884 USE OF FANA ANTISENSE OLIGONUCLEOTIDES FOR THE PREVENTION AND MANAGEMENT OF HUANGLONGBING AND ZEBRA CHIP DISEASES CHATTERJEE, JAYANTA 53d overdue
17370759 IDENTIFYING TRANSITION POINTS IN CHEMICAL REACTIONS MINCHELLA, KAITLYN L 1d overdue
17818159 XANTHINE OXIDASE INHIBITOR FORMULATIONS HUANG, GIGI GEORGIANA 14d
18247474 RAPID DIAGNOSTIC ELECTROCHEMICAL BIOSENSING TARGETED WITH ANTISENSE OLIGONUCLEOTIDES TURPIN, ZACHARY MARK 19d
17918052 SHEATH/CATHETER SECURING DEVICE ALLEN, ROBERT F 27d
18173962 THERAPEUTIC TARGETING OF GPR68 TO INDUCE FERROPTOSIS ELENISTE, PIERRE PAUL 36d
18015169 BIOFLUID-BASED PROTEIN AND MIRNA BIOMARKERS FOR NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY MCCOLLUM, ANDREA K 60d

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18021884 USE OF FANA ANTISENSE OLIGONUCLEOTIDES FOR THE PREVENTION AND MANAGEMENT OF HUANGLONGBING AND ZEBRA CHIP DISEASES CHATTERJEE, JAYANTA 53d overdue
18114014 T-DNA Free Gene Editing through Transient Suppressing POLQ in Plants CHATTERJEE, JAYANTA 5d overdue
18777102 BAG-IN-BOX PACKAGING DEMEREE, CHRISTOPHER R 21d
19199855 MAGNETIC STEREOLITHOGRAPHY PRINT HEAD, STEREOLITHOGRAPHY PRINTER, AND METHOD OF STEREOLITHOGRAPHY PRINTING KENNEDY, TIMOTHY J
18848353 APPARATUS AND METHOD FOR ATTACHING A HANDS-FREE LENS TO A MICROSCOPE FOR USE DURING OCULAR SURGERY NIGAM, NATASHA
18846353 METHOD AND APPARATUS FOR ACHIEVING HIGH ELECTROSPRAY DEPOSITION EFFICIENCY ON LOW AREA TARGETS MELLOTT, JAMES M
18832702 COMPOSITIONS (III) LI, CHANGQING
18711193 FRAGRANCES AND FRAGRANCE MIXTURES AHVAZI, BIJAN

Client Portfolio (27 clients)

Top Art Units

Art UnitApps
16624
17794
17592
16452
16742
37341
17881
17261
16571
16541

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19199855 MAGNETIC STEREOLITHOGRAPHY PRINT HEAD, STEREOLITHOGRAPHY PRINTER, AND METHOD OF STEREOLITHOGRAPHY PRINTING UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. KENNEDY, TIMOTHY J §102§103§112 Non-Final OA Pending May 06, 2025
18998662 SINGLE CRYSTAL SAPPHIRE COMPONENT FOR ANGULAR CONTROL DURING SOLID STATE NUCLEAR MAGNETIC RESONANCE MEASUREMENTS Rutgers, The State University Of New Jersey AURORA, REENA §112 Non-Final OA Pending Jan 27, 2025
18848353 APPARATUS AND METHOD FOR ATTACHING A HANDS-FREE LENS TO A MICROSCOPE FOR USE DURING OCULAR SURGERY Oculus Surgical, Inc. NIGAM, NATASHA §102 Non-Final OA Pending Sep 18, 2024
18846353 METHOD AND APPARATUS FOR ACHIEVING HIGH ELECTROSPRAY DEPOSITION EFFICIENCY ON LOW AREA TARGETS Rutgers, The State University Of New Jersey MELLOTT, JAMES M 1759 §102§103§112 Non-Final OA Pending Sep 12, 2024
18832702 COMPOSITIONS (III) Symrise AG LI, CHANGQING §101§103§112 Non-Final OA Pending Jul 24, 2024
18777102 BAG-IN-BOX PACKAGING DMK DEUTSCHES MILCHKONTOR GMBH DEMEREE, CHRISTOPHER R 3734 §103 Non-Final OA 21d Pending Jul 18, 2024
18576480 ANIONIC EXPLOSION-PROOF MEMBRANE AND PREPARATION METHOD THEREFOR Hubei Institute Of Aerospace Chemical Technology DESAI, ANISH P 1788 §112 Non-Final OA Pending Jun 11, 2024
18711193 FRAGRANCES AND FRAGRANCE MIXTURES Symrise AG AHVAZI, BIJAN §103§112 Non-Final OA Pending May 17, 2024
18706881 IMPROVED GENETIC TRANSFORMATION BY IMPROVING DE-NOVO SHOOT REGENERATION IN ADULT PLANTS AND DURING IN-VITRO TISSUE CULTURE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. JOHNSON, EMILY KATHARINE 1662 §102§103§112 Final Rejection Pending May 02, 2024
18700490 A Novel Poultry Salmonella Vaccine and Diagnostic Methodology to Control Foodborne Salmonellosis The Penn State Research Foundation GRASER, JENNIFER E 1645 §101§102§103§112 Non-Final OA Pending Apr 11, 2024
18627775 METHODS FOR PASSIVATING PEROVSKITE SOLAR CELLS AND RELATED DEVICES The Governing Council of the University of Toronto PILLAY, DEVINA 1726 §102§103§112 Non-Final OA 80d overdue Pending Apr 05, 2024
18608239 AN ENZYMATIC PROCESS FOR PRODUCING HYDROXYCINNAMIC ACID AMIDES (HCAA) Analyticon Discovery GmbH YAMASAKI, ROBERT J 1657 §112 Non-Final OA 76d Pending Mar 18, 2024
18580710 EARLY DETECTION OF INNATE IMMUNE DYSFUNCTION AND TREATMENT OF CONDITIONS ASSOCIATED THEREWITH UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. MACFARLANE, STACEY NEE 1645 §101§102§103§112Other Non-Final OA Pending Jan 19, 2024
18488234 BONE DISEASE TREATMENT The University of Birmingham ESPINOSA, CLAUDIA EDILMA 1654 §102§112 Non-Final OA Pending Oct 17, 2023
18555268 PORTABLE ULTRASOUND DEVICE FOR IMAGING A SUB-CUTANEOUS STRUCTURE AND METHOD FOR ULTRASONIC IMAGING Veintech Pty Ltd. CELESTINE, NYROBI I 3798 §103 Final Rejection 11d overdue Pending Oct 13, 2023
18279672 NOVEL PSEUDOMONAS STRAIN FOR METAL RECOVERY Brain Biotech AG STEADMAN, DAVID J 1656 §101 Final Rejection Pending Aug 31, 2023
18271884 METHOD AND APPARATUS FOR AUTOMATING MODELS FOR INDIVIDUALIZED ADMINISTRATION OF MEDICAMENTS UNIVERSITY OF MARYLAND, BALTIMORE NGUYEN, HIEP VAN 3686 §101§103 Non-Final OA Pending Jul 12, 2023
18268625 A kit of parts for dental restoration Stick Tech OY SALAMON, PETER A 1759 §103 Non-Final OA Pending Jun 21, 2023
18268280 CREATE HUANGLONGBING TOLERANCE BY SILENCING A CITRUS NEGATIVE IMMUNE REGULATOR UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. DELEO, VICTORIA LYNN 1662 §102§103 Final Rejection Pending Jun 19, 2023
18038321 USE OF INSULIN-LIKE GROWTH FACTORS WITH GAMMA-CHAIN CYTOKINES TO INDUCE HOMEOSTATIC PROLIFERATION OF LYMPHOCYTES UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. SULLIVAN, DENNIS JOHN 1642 §103 Non-Final OA Pending May 23, 2023
18321062 COMPOSITION AND METHOD FOR CONTROLLING HEAT GENERATION WITHIN ORGANISM, AND USE Guangdong Jiantebo Biotechnology Co., Ltd. HOWARD, ZACHARY C 1674 §102§112 Non-Final OA Pending May 22, 2023
18137022 METHODS AND COMPOSITIONS FOR CONTROL OF ARTHROPOD PESTS Greenlight Biosciences, Inc. HUDSON, AMY ROSE 1636 §103§112 Final Rejection Pending Apr 20, 2023
18247474 RAPID DIAGNOSTIC ELECTROCHEMICAL BIOSENSING TARGETED WITH ANTISENSE OLIGONUCLEOTIDES UNIVERSITY OF MARYLAND, BALTIMORE TURPIN, ZACHARY MARK 1682 §102§103§112 Non-Final OA 19d Pending Mar 31, 2023
18125960 TREATMENT OF AQUEOUS SYSTEMS Mfg Chemical, LLC GEISBERT, WILLIAM ADDISON 1779 §103§112 Non-Final OA Pending Mar 24, 2023
18125949 TREATMENT OF AQUEOUS SYSTEMS Mfg Chemical, LLC GEISBERT, WILLIAM ADDISON 1779 §103§112 Non-Final OA Pending Mar 24, 2023
18125937 TREATMENT OF AQUEOUS SYSTEMS Mfg Chemical, LLC GEISBERT, WILLIAM ADDISON 1779 §103§112 Non-Final OA Pending Mar 24, 2023
18178192 AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1 The Trustees of Columbia University in the City of New York FETTEROLF, BRANDON J 1626 §102 Non-Final OA 56d overdue Pending Mar 03, 2023
18024444 PHARMACEUTICAL COMPOSITION USEFUL FOR PROMOTING OSTEOBLASTOGENESIS BIOCODEX BOECKELMAN, JACOB A 1655 §103 Non-Final OA Pending Mar 02, 2023
18114014 T-DNA Free Gene Editing through Transient Suppressing POLQ in Plants UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. CHATTERJEE, JAYANTA 1662 §103 Final Rejection 5d overdue Pending Feb 24, 2023
18173962 THERAPEUTIC TARGETING OF GPR68 TO INDUCE FERROPTOSIS UNIVERSITY OF MARYLAND, BALTIMORE ELENISTE, PIERRE PAUL 1622 §103§112Other Non-Final OA 36d Pending Feb 24, 2023
18021884 USE OF FANA ANTISENSE OLIGONUCLEOTIDES FOR THE PREVENTION AND MANAGEMENT OF HUANGLONGBING AND ZEBRA CHIP DISEASES Aum Lifetech, Inc. CHATTERJEE, JAYANTA 1662 §103§112Other Final Rejection 53d overdue Pending Feb 17, 2023
18040439 ENGINEERING DIVERSE ANTIGEN-PRESENTING CELLS TO CONTROL ANTIGEN-SPECIFIC RESPONSES UNIVERSITY OF MARYLAND, BALTIMORE SHIN, MONICA A 1616 §103 Non-Final OA 41d Pending Feb 03, 2023
18015169 BIOFLUID-BASED PROTEIN AND MIRNA BIOMARKERS FOR NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY The United States Department of Veterans Affairs MCCOLLUM, ANDREA K 1674 §101§102§112 Non-Final OA 60d Pending Jan 09, 2023
18055333 APPARATUS AND METHOD FOR AIRBORNE PATHOGEN DETECTION USING AN ELECTROCHEMICAL PLATFORM UNIVERSITY OF MARYLAND, BALTIMORE SINGER, DAVID L 2855 §103 Non-Final OA Pending Nov 14, 2022
17923345 BIOMARKERS FOR ASSESSING LIVER DISEASE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. KAPUSHOC, STEPHEN THOMAS 1683 §101§103§112 Non-Final OA Pending Nov 04, 2022
17918052 SHEATH/CATHETER SECURING DEVICE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. ALLEN, ROBERT F 3783 §102§103 Non-Final OA 27d Pending Oct 10, 2022
17911789 METHODS OF TREATING VIRAL INFECTIONS AND HEALTH CONSEQUENCES Allen Davidoff ROBINSON, HOPE A 1652 §112 Non-Final OA Pending Sep 15, 2022
17911026 METHODS, DEVICES, AND COMPOSITIONS FOR LESION REPAIR AND PREVENTION UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. NGUYEN, NGOC-ANH THI 1615 §103 Final Rejection Pending Sep 12, 2022
17818159 XANTHINE OXIDASE INHIBITOR FORMULATIONS Xortx Therapeutics, Inc. HUANG, GIGI GEORGIANA 1613 §101§102§103§112Other Non-Final OA 14d Pending Aug 08, 2022
17782839 NOZZLE BLOCK PROVIDED WITH NOZZLE CLOGGING PREVENTION MEANS, AND ELECTROSPINNING DEVICE INCLUDING THE SAME Jong-Su Park TAUFIQ, FARAH N 1754 §103 Final Rejection 77d Pending Jun 06, 2022
17743603 TREATMENT OF AQUEOUS SYSTEMS Radical Polymers, LLC GEISBERT, WILLIAM ADDISON 1779 §103DP Non-Final OA Pending May 13, 2022
17598695 SELECTIVE FOXO INHIBITORS FOR TREATMENT OF DIABETES AND OTHER DISORDERS RELATED TO IMPAIRED PANCREATIC FUNCTION The Trustees Of Columbia Universityin The City Of New York ROMERO, KRISTEN WANG 1624 §102 Non-Final OA 73d overdue Pending Sep 27, 2021
17370759 IDENTIFYING TRANSITION POINTS IN CHEMICAL REACTIONS Azure Vault Ltd. MINCHELLA, KAITLYN L 1685 §101§112Other Non-Final OA 1d overdue Pending Jul 08, 2021
17161641 COMPOSITIONS AND METHODS FOR CONTROLLING ARTHROPOD PARASITE AND PEST INFESTATIONS Greenlight Biosciences, Inc. TRAN, CHRISTINA L 1637 DPOther Non-Final OA Pending Jan 28, 2021
16813263 Methods of Generating Mature Human Muscle Fibers UNIVERSITY OF MARYLAND, BALTIMORE POPA, ILEANA 1633 §103Other Non-Final OA 89d overdue Pending Mar 09, 2020

Managing Wolter Van Dyke Davis, Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month